Qingdao Baheal Medical INC.

301015

CNE100004LR8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 17/05/2024 am IST			5-day change	1st Jan Change
33.23 ^CNY	+1.90%		+0.76%	-7.33%

22/04	Qingdao Baheal Medical INC. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Qingdao Baheal Medical INC. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Qingdao Baheal Medical INC. has filed an IPO.

November 23, 2020 at 10:30 am IST

Qingdao Baheal Medical INC. has filed an IPO.

Security Name: A shares
Security Type: Common Stock
Securities Offered: 52,600,000

Transaction Features: Sponsor Backed Offering

Latest news about Qingdao Baheal Medical INC.

Qingdao Baheal Medical INC. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/04	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Nine Months Ended September 30, 2023	26/23/26	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
Certain A Shares of Qingdao Baheal Medical INC. are subject to a Lock-Up Agreement Ending on 1-JUL-2023.	01/23/01	CI
Qingdao Baheal Medical Inc. Approves Cash Dividend for the Year of 2022, Payable on 25 May 2023	17/23/17	CI
Qingdao Baheal Medical INC. Announces Final Cash Dividend Proposal for 2022	26/23/26	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Full Year Ended December 31, 2022	24/23/24	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Qingdao Baheal Medical INC.(XSEC:301015) added to S&P Global BMI Index	19/22/19	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the Half Year Ended June 30, 2022	16/22/16	CI
Qingdao Baheal Medical Inc. Announces Management Appointments	06/22/06	CI
Sinohealth Raises $43 Million in Hong Kong IPO	11/22/11	MT
Certain A Shares of Qingdao Baheal Medical INC. are subject to a Lock-Up Agreement Ending on 1-JUL-2022.	01/22/01	CI
Qingdao Baheal Medical to List 12.5% Stake Post IPO Lock-Up	30/22/30	MT
Qingdao Baheal Medical INC. Announces Final Dividend on A Shares for the Year 2021, Payable on May 25, 2022	20/22/20	CI
Qingdao Baheal Medical Inc. Approves Dividend for 2021	18/22/18	CI
Qingdao Baheal Medical INC. Announces Final Cash Dividend Proposal for 2021	27/22/27	CI
Qingdao Baheal Medical INC. Reports Earnings Results for the First Quarter Ended March 31, 2022	25/22/25	CI
Qingdao Baheal Medical to List 2.9 Million Shares Post IPO Lockup Period	29/21/29	MT
Qingdao Baheal Medical INC. Reports Earnings Results for the Nine Months Ended September 30, 2021	28/21/28	CI
Qingdao Baheal Medical INC. has completed an IPO in the amount of CNY 401.864 million.	22/21/22	CI
Qingdao Baheal Medical INC. has filed an IPO.	23/20/23	CI

Chart Qingdao Baheal Medical INC.

Duration

Period

More charts

Qingdao Baheal Medical Inc is a China-based company mainly providing comprehensive marketing services for pharmaceutical product manufacturers. The Company provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The Company's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The Company mainly conducts its business within domestic market.

Sector

Pharmaceuticals

Calendar

14/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Qingdao Baheal Medical INC.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

33.23 CNY

Average target price

48 CNY

Spread / Average Target

+44.45%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
QINGDAO BAHEAL MEDICAL INC.	-7.33%	2.42B
MCKESSON CORPORATION	+21.93%	73.38B
CARDINAL HEALTH, INC.	-1.71%	24.13B
SINOPHARM GROUP CO. LTD.	+7.58%	8.78B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+10.34%	8.59B
HUADONG MEDICINE CO., LTD	-19.80%	8.06B
H. LUNDBECK A/S	+14.16%	5.26B
EBOS GROUP LIMITED	-0.03%	4.21B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+12.70%	4.17B
GALENICA AG	-2.54%	3.89B

Pharmaceuticals Wholesale